Rapid Micro Biosystems Q1 2024 GAAP EPS $(0.31) Misses $(0.29) Estimate, Sales $5.611M Beat $5.500M Estimate
Rapid Micro Biosystems Q1 2024 GAAP EPS $(0.31) Misses $(0.29) Estimate, Sales $5.611M Beat $5.500M Estimate
Rapid Micro Biosystems 2024年第一季度GAAP每股收益（0.31）未達到預期（0.29）美元，銷售額超過561.1萬美元的預期
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.29) by 6.9 percent. This is a 3.13 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $5.611 million which beat the analyst consensus estimate of $5.500 million by 2.02 percent. This is a 11.44 percent increase over sales of $5.035 million the same period last year.
Rapid Micro Biosystems（納斯達克股票代碼：RPID）公佈的季度虧損爲每股0.31美元，比分析師共識估計的0.29美元（0.29美元）低6.9％。這比去年同期每股虧損0.32美元（0.32美元）增長了3.13％。該公司公佈的季度銷售額爲561.1萬美元，比分析師普遍預期的55億美元高出2.02％。這比去年同期的503.5萬美元的銷售額增長了11.44％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。